Cost-effectiveness Analysis of Treatments for Hyperlipidemia. Lower Medical Cost by Nutritional Therapy.

DOI Web Site 2 Citations 17 References

Bibliographic Information

Other Title
  • 高脂血症における治療法別費用効果分析　　栄養指導における医療費削減効果
  • コウシケツショウ ニ オケル チリョウホウ ベツ ヒヨウ コウカ ブンセキ エイヨウ シドウ ニ オケル イリョウヒ サクゲン コウカ
  • Lower Medical Cost by Nutritional Therapy
  • 栄養指導における医療費削減効果

Search this article

Description

We analyzed the medical cost for a year of patients with hyperlipidemia according to the Mark method for analyzing cost-effectiveness. The patients were divided into groups undergoing nutritional therapy alone (N group: 38), nutritional therapy combined with drugs (N-D group: 17), and drug therapy (D group: 20). The medical cost included all drug charges, prescription charges and/or nutritional therapy. The total cost for one year was \42, 122 (337) (at 1=\125) for each patient in the N group, which was \90, 000-100, 000 less expensive than the costs for the N-D group and D group, being related to the types of drugs and the complications.<br>These patients with hypercholesterolemia (high-TC) showed no difference in TC reduction among the groups. These patients with a TC level of more than 260mg/dl showed a greater TC reduction in the N group than in the D group (-14.8±10.9% vs-4.7±9.7%, p<0.05). The total cost/patient in the N group was \61, 748 (494), this being \140, 000-160, 000 less expensive than the N-D group and the D group patients. The proportion of patients who could be effectively treat for \10, 000 (80) was 16.2% in the N group.<br>These patients with a TC level of less than 260mg/dl showed a greater TC reduction in the N than in the D group. The annual cost for patients less than 65 years old was less than for these more than 65 years old. These patients with a triglyceride (TG) level of more than 150mg/dl (high-TG) showed no difference in TG reduction among the groups. However, the ratio of patients with a TG level 10% less than that at the start of study was more than in the other groups. Therefore, the annual total cost/patient for the N group was \54, 367 (435), compared with \80, 000 (640) and \180, 000 ($1, 440) for the N-D group and the D group.<br>Nutritional therapy for the patients with a TC level of more than 260mg/dl, for younger patients less than 65 years old and for the patients with high TG was more cost-effective than the treatments for the N-D group and the D group. Therefore, nutritional therapy should be considered as the primary treatment in terms of reducing medical cost.

Journal

Citations (2)*help

See more

References(17)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top